Bank of America
ALT icon

Bank of America’s Altimmune ALT Stock Holding History

Bank of America’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Buy
570,203
+186,420
+49% +$792K ﹤0.01% 4201
2025
Q4 		$1.39M Buy
383,783
+63,343
+20% +$276K ﹤0.01% 4328
2025
Q3 		$1.21M Sell
320,440
-395,579
-55% -$1.53M ﹤0.01% 5195
2025
Q2 		$2.77M Buy
716,019
+435,467
+155% +$2.36M ﹤0.01% 4454
2025
Q1 		$1.4M Buy
280,552
+98,663
+54% +$625K ﹤0.01% 4980
2024
Q4 		$1.31M Buy
181,889
+32,382
+22% +$247K ﹤0.01% 4800
2024
Q3 		$918K Sell
149,507
-129,831
-46% -$880K ﹤0.01% 5101
2024
Q2 		$1.86M Sell
279,338
-220,534
-44% -$1.63M ﹤0.01% 4492
2024
Q1 		$5.09M Buy
499,872
+472,895
+1,753% +$4.81M ﹤0.01% 3592
2023
Q4 		$303K Sell
26,977
-33,522
-55% -$140K ﹤0.01% 5830
2023
Q3 		$157K Sell
60,499
-21,174
-26% -$60.7K ﹤0.01% 6030
2023
Q2 		$288K Sell
81,673
-564,473
-87% -$2.53M ﹤0.01% 5603
2023
Q1 		$2.73M Buy
646,146
+116,510
+22% +$1.38M ﹤0.01% 4081
2022
Q4 		$8.71M Buy
529,636
+267,432
+102% +$3M ﹤0.01% 2827
2022
Q3 		$3.35M Buy
262,204
+197,231
+304% +$2.91M ﹤0.01% 3775
2022
Q2 		$760K Buy
64,973
+42,135
+184% +$260K ﹤0.01% 5134
2022
Q1 		$140K Sell
22,838
-202,732
-90% -$1.49M ﹤0.01% 6676
2021
Q4 		$2.07M Buy
225,570
+204,148
+953% +$2.17M ﹤0.01% 4515
2021
Q3 		$243K Buy
21,422
+3,025
+16% +$36.8K ﹤0.01% 6177
2021
Q2 		$181K Sell
18,397
-4,578
-20% -$62.6K ﹤0.01% 6153
2021
Q1 		$325K Buy
+22,975
New +$371K ﹤0.01% 5698
2020
Q3 		– Sell
-302,299
Closed -$3.24M – 6865
2020
Q2 		$3.24M Buy
+302,299
New +$1.66M ﹤0.01% 3242
2020
Q1 		– Sell
-25,000
Closed -$47K – 6808
2019
Q4 		$47K Sell
25,000
-34
-0.1% -$63 ﹤0.01% 6275
2019
Q3 		$49K Sell
25,034
-24,966
-50% -$55.3K ﹤0.01% 6328
2019
Q2 		$119K Buy
+50,000
New +$134K ﹤0.01% 5913
2018
Q4 		– Sell
-23
Closed – – 7075
2018
Q3 		$0 Buy
+23
New +$250 ﹤0.01% 7241
2017
Q3 		– Sell
-115
Closed -$11K – 7027
2017
Q2 		$11K Buy
115
+49
+74% +$8.14K ﹤0.01% 6397
2017
Q1 		$16K Buy
66
+26
+65% +$13.9K ﹤0.01% 6386
2016
Q4 		$40K Buy
40
+11
+38% +$9.86K ﹤0.01% 6027
2016
Q3 		$25K Buy
29
+7
+32% +$5.49K ﹤0.01% 6035
2016
Q2 		$16K Sell
22
-20
-48% -$13.7K ﹤0.01% 6330
2016
Q1 		$24K Buy
42
+3
+8% +$1.53K ﹤0.01% 6061
2015
Q4 		$22K Sell
39
-34
-47% -$16.9K ﹤0.01% 6384
2015
Q3 		$29K Buy
73
+55
+306% +$26.1K ﹤0.01% 6180
2015
Q2 		$10K Sell
18
-64
-78% -$32.3K ﹤0.01% 6578
2015
Q1 		$40K Hold
82
– – ﹤0.01% 5759
2014
Q4 		$45K Hold
82
– – ﹤0.01% 6404
2014
Q3 		$44K Hold
82
– – ﹤0.01% 6583
2014
Q2 		$35K Buy
+82
New +$37.1K ﹤0.01% 6882
2014
Q1 		– Hold
0
– – – 7756
2013
Q4 		– Hold
0
– – – 7858
2013
Q3 		– Hold
0
– – – 7850
2013
Q2 		– Hold
0
– – – 7675

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of America's ALT Position: Q1 2026 in Review

Bank of America increased its Altimmune (ALT) stake by 49% in Q1 2026, buying an estimated $792K and bringing the position to 570,203 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #4201.

Bank of America first reported a position in ALT in Q2 2014 and has held it in 39 quarters since. The position peaked at $8.71M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Bank of America held 570,203 shares of Altimmune worth $1.76M as of Q1 2026.
  • Bank of America bought 186,420 Altimmune shares in Q1 2026, an estimated $792K.
  • Altimmune made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4201 holding.
  • Bank of America first reported a position in Altimmune in Q2 2014 and has held it in 39 quarters since.
  • Bank of America's Altimmune position peaked at $8.71M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.